Localized Discoid Lupus Erythematosus of the Auricular Concha: A Case Report Highlighting the Diagnostic Relevance of the Carpet Tack Sign. [PDF]
Muñoz MP, Caceres CL, Morales C.
europepmc +1 more source
Plain Language Summary Recent studies have found an association between migraine and several chronic inflammatory diseases, such as multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis, suggesting that these conditions might share common immune and vascular pathways.
María Clara García‐Castillo +37 more
wiley +1 more source
Dermatological Indicators of Systemic Autoimmune Disease: Clinical Links to Ocular Involvement. [PDF]
Abbas H +7 more
europepmc +1 more source
Post‐Inflammatory Hyperpigmentation: Molecular Mechanisms and Advances in Dermocosmetic Management
ABSTRACT Background Post‐inflammatory hyperpigmentation (PIH) is a condition that causes skin pigmentation after acute or chronic inflammation. It affects people with darker skin tones more than others, especially Asians (Fitzpatrick types III–VI), and can last for months or even years, making life much less enjoyable.
Rui Li +10 more
wiley +1 more source
Chronic heat-induced discoid lupus erythematosus. [PDF]
Araghi S, Pham CT, Ederaine S, Linden K.
europepmc +1 more source
Treatment of Reactive Histiocytosis With Oclacitinib: A Retrospective Case Series of 10 Dogs
Background: Canine reactive histiocytosis is a proliferative disorder of activated interstitial dendritic cells with cutaneous and systemic forms. An immune‐mediated aetiology is likely, and systemic immunomodulatory agents such as corticosteroids, tetracycline/niacinamide, ciclosporin, azathioprine and leflunomide have been employed for its management.
Christine L. Cain +2 more
wiley +1 more source
Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data. [PDF]
Lin A +3 more
europepmc +1 more source
Drug-Induced Subacute Cutaneous Lupus Secondary to Sulfasalazine. [PDF]
Choi K, Truong L, Kang Y.
europepmc +1 more source
A Novel Use of Anifrolumab for a Novel Disease. [PDF]
Holtz Z, Schulz A, Meara A.
europepmc +1 more source

